Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Clinical Outcomes of Optimize Treatment of Chronic Hepatitis B Patients With Low-level Viremia Undergoing Nucleoside Treatment

NCT05357183 is registered in ClinicalTrials.gov with Beijing Ditan Hospital as lead sponsor.

NCT NCT05357183
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05357183 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Clinical Outcomes of Optimize Treatment of Chronic Hepatitis B Patients With Low-level Viremia Undergoing Nucleoside Treatment
Lead sponsor
Beijing Ditan Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2022
Completion date
December 31, 2024
Enrollment
1,200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b